Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Acquisitions & Divestments: 2022-2025

Historic Change in Acquisitions & Divestments for Praxis Precision Medicines (PRAX) over the last 3 years, with Sep 2025 value amounting to $125.5 million.

  • Praxis Precision Medicines' Change in Acquisitions & Divestments rose 104.06% to $125.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $309.3 million, marking a year-over-year increase of 198.80%. This contributed to the annual value of $123.0 million for FY2024, which is 215.45% up from last year.
  • According to the latest figures from Q3 2025, Praxis Precision Medicines' Change in Acquisitions & Divestments is $125.5 million, which was up 111.72% from $59.3 million recorded in Q2 2025.
  • Over the past 5 years, Praxis Precision Medicines' Change in Acquisitions & Divestments peaked at $125.5 million during Q3 2025, and registered a low of $3.0 million during Q2 2024.
  • Its 3-year average for Change in Acquisitions & Divestments is $51.6 million, with a median of $58.9 million in 2024.
  • Per our database at Business Quant, Praxis Precision Medicines' Change in Acquisitions & Divestments tumbled by 85.71% in 2023 and then spiked by 1,876.57% in 2025.
  • Quarterly analysis of 4 years shows Praxis Precision Medicines' Change in Acquisitions & Divestments stood at $22.6 million in 2022, then tumbled by 85.71% to $5.0 million in 2023, then slumped by 40.00% to $58.5 million in 2024, then spiked by 104.06% to $125.5 million in 2025.
  • Its last three reported values are $125.5 million in Q3 2025, $59.3 million for Q2 2025, and $66.0 million during Q1 2025.